Abstract A055: Integrative epigenomic characterization of MGMT and LINE-1 methylation in diffuse gliomas and colorectal cancer: insights from rare brain tumors
Joint assessment of MGMT and LINE-1 methylation uncovers an aggressive epigenomic subtype of rare brain tumors that phenocopies CRC epigenetic features and suggest conserved epigenomic vulnerabilities exploitable by hypomethylating agents.